Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 227

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 227
---
, Anupam Dalal and Karin Hehenberger currently serve on the Nominating and Corporate Governance Committee, which is chaired by Dr. Dalal. Our board of directors has determined that each member of the Nominating and Corporate Governance Committee is “independent” as defined in the applicable Nasdaq rules. The Nominating and Corporate Governance Committee’s responsibilities include:

| • |     | reviewing, assessing and recommending to the board of directors criteria for board and committee membership; |

| • |     | establishing procedures for identifying and evaluating board of director candidates, including nominees 
 recommended by stockholders;                                                                            |

| • |     | reviewing the composition of the board of directors to ensure that it is composed of members containing the 
 appropriate skills and expertise to advise us;                                                              |

| • |     | identifying individuals qualified to become members of the board of directors based on the established criteria; |

| • |     | overseeing the Company’s director orientation and continuing education, including making recommendations for                                                 
 continuing education of board members and evaluating the participation of members of the board of directors in accordance with applicable listing standards; |

| • |     | recommending to the board of directors the persons to be nominated for election as directors and to each of the 
 board of directors committees;                                                                                  |

- 157 -

| • |     | administering policies and procedures for various constituencies that are involved with the Company to 
 communicate with the non-management board members;                                                     |

| • |     | developing and recommending to the board of directors corporate governance guidelines and reviewing the corporate 
 governance guidelines and their application;                                                                      |

| • |     | developing, approving, reviewing, and monitoring compliance with the Company’s Code of Business Conduct and 
 Ethics and considering potential conflicts of interest of board members and other corporate officers; and   |

| • |     | overseeing the evaluation of our board of directors and management. |

The Nominating and Corporate Governance Committee held one (1) meeting during 2024. A copy of the Nominating and Corporate Governance Committee Charter is available on the Company’s website at www.aadibio.comunder the Investors & News section. Our board of directors may from time to time establish other committees. Corporate Governance Guidelines Aadi’s board of directors has adopted corporate governance guidelines to assist and guide its members in the exercise of its responsibilities. These guidelines should be interpreted in accordance with any requirements imposed by applicable federal or state law or regulation and our Certificate of Incorporation and bylaws. Our corporate governance guidelines are available on